financetom
Business
financetom
/
Business
/
Hermes Q3 sales up 11.3%, continues to outshine rivals
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hermes Q3 sales up 11.3%, continues to outshine rivals
Oct 31, 2024 2:09 AM

By Mimosa Spencer

PARIS, Oct 24 (Reuters) - Birkin bag maker Hermes

reported on Thursday an 11.3% rise in third-quarter

sales, continuing to outshine rivals hit hard by a downturn in

China as its luxury handbags lure wealthy shoppers.

The French luxury company generated 3.7 billion euros

($3.99 billion) in revenue for the three months ending in

September, an 11.3% rise at constant exchange rates.

The figure was in line with an analyst consensus estimate of

11% growth cited by Jefferies.

"In a more uncertain economic and geopolitical context, I

want to thank all employees for the robust third-quarter

performance, and our customers for their loyalty," said Axel

Dumas, Executive Chairman of Hermes.

"Thanks to the singularity of its model, Hermes is

continuing its recruitments and long-term investments," he said

in a statement.

A sector-wide slowdown has affected labels across the

high-end spectrum.

Luxury bellwether LVMH missed expectations last week and

flagged a drop in Chinese consumer confidence to COVID-era lows,

with a deterioration in demand for fashion over the quarter.

Late on Wednesday, Kering warned its 2024

operating income would almost halve to its lowest in years as

weak demand in China deepened the struggles of the French luxury

goods group's main label Gucci.

Hermes' famously classic designs and tight management of

production and stock have helped reinforce the label's aura of

exclusivity and made the company one of the most consistent

performers in the industry.

Handbags like the coveted $10,000 plus Birkin model are

affordable only for the wealthiest shoppers -- who are typically

the more immune to choppy economic conditions.

But showing limits of its resilience, executives earlier

this year said that Hermes was seeing slightly less traffic from

aspirational clients, impacting higher volume products like

fashion accessories such as silk scarves.

Hermes shares have risen nearly 9% since the start of the

year, outpacing rivals, with LVMH down nearly 15%, Moncler down

3.3% and Kering, which is working to turn around

Gucci, down 40%.

($1 = 0.9267 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved